Filter by: patients
What is Chlorthalidone?

Chlorthalidone is a thiazide diuretic used to manage mild-to-moderate hypertension when used alone or in combination with other agents and for the treatment of edema associated with congestive heart failure or nephrotic syndrome.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Elevated blood pressure 2 0
Hypertension 2 0
Other 1 0
Edema (fluid retention) 1 1 Efficacy_cant_tell
Water retention 1 0
General health 1 0

See all 10 patients currently taking Chlorthalidone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
1

Commonly reported side effects, conditions, and hospitalizations associated with Chlorthalidone

Frequent night time urination 1

Reported Dosages

  15 mg daily 25 mg daily 50 mg daily
  1 Number of Patients: 1 7 Number of Patients: 7 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Chlorthalidone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 1   Doctor's advice: 50%

See all 1 patient who’ve stopped taking Chlorthalidone

Currently Taking Chlorthalidone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Stopped Taking Chlorthalidone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Chlorthalidone

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Chlorthalidone

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

Cost of Chlorthalidone

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.